Regulation of biliary proliferation by neuroendocrine factors: Implications for the pathogenesis of cholestatic liver diseases

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 472-484

  Munshi, Md Kamruzzaman ^a,b   Priester, Sally ^c   Gaudio, Eugenio ^d   Yang, Fuquan ^e   Alpini, Gianfranco ^a,b,c,f   Mancinelli, Romina ^d   Wise, Candace ^a   Meng, Fanyn ^a,b,c   Franchitto, Antonio ^d   Onori, Paolo ^g   Glaser, Shannon S ^a,b,c  

^a Texas A and M University   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e CHINA MEDICAL UNIVERSITY   (China)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADRENALIN; ANANDAMIDE; ANGIOGENIC FACTOR; CYCLIC AMP; GASTRIN; GASTROINTESTINAL HORMONE; GROWTH FACTOR; HISTAMINE; METENKEPHALIN; NEUROPEPTIDE; NEUROTRANSMITTER; NORADRENALIN; OPIATE RECEPTOR; PEPTIDE HORMONE; SECRETIN; SEROTONIN 5 RECEPTOR; SEX HORMONE; SOMATOSTATIN;

ADRENERGIC NERVE; BILE DUCT; BILE DUCT DISEASE; CELL FUNCTION; CELL PROLIFERATION; CHOLESTASIS; CHOLESTATIC HEPATITIS; CHOLESTATIC LIVER DISEASE; CHOLINERGIC SYSTEM; DOPAMINERGIC NERVE CELL; EXTRAHEPATIC BILE DUCT OBSTRUCTION; HEPATOBILIARY SYSTEM; HORMONE RELEASE; HUMAN; INNERVATION; LIVER CELL; LIVER DISEASE; LIVER INJURY; NEUROENDOCRINE SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENSORY NERVE; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

EID: 79951821299     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.09.043     Document Type: Review

References (100)

1. Alpini G, Prall RT, LaRusso NF: The pathobiology of biliary epithelia. The Liver: Biology & Pathobiology, ed 4, ch 29. Edited by IM Arias, JL Boyer, FV Chisari, N Fausto, W Jakoby, D Schachter, DA Shafritz. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 421-435
2. Alpini G, Lenzi R, Sarkozi L, Tavoloni N: Biliary physiology in rats with bile ductular cell hyperplasia: evidence for a secretory function of proliferated bile ductules. J Clin Invest 1988, 81:569-578 (Pubitemid 18075253)
3. LeSage G, Glaser S, Marucci L, Benedetti A, Phinizy JL, Rodgers R, Caligiuri A, Papa E, Tretjak Z, Jezequel AM, Holcomb LA, Alpini G: Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. Am J Physiol Gastrointest Liver Physiol 1999, 276:G1289-G1301 (Pubitemid 29251929)
4. Glaser S, Gaudio E, Miller T, Alvaro D, Alpini G: Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 2009, 11:e7
5. Kanno N, LeSage G, Glaser S, Alpini G: Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 2001, 281:G612-G625
6. Alpini G, Ulrich CD II, Phillips JO, Pham LD, Miller LJ, LaRusso NF: Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 1994, 266:G922-G928
7. Glaser S, Alvaro D, Roskams T, Phinizy JL, Stoica G, Francis H, Ueno Y, Barbaro B, Marzioni M, Mauldin J, Rashid S, Mancino MG, LeSage G, Alpini G: Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-γ expression and decrease of PKA activity. Am J Physiol Gastrointest Liver Physiol 2003, 284:G683-G694 (Pubitemid 36343218)
8. Alpini G, Ulrich C, Roberts S, Phillips JO, Ueno Y, Podila PV, Colegio O, LeSage G, Miller LJ, LaRusso NF: Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 1997, 272:G289-G297
9. LeSage G, Glaser S, Gubba S, Robertson WE, Phinizy JL, Lasater J, Rodgers RE, Alpini G: Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. Gastroenterology 1996, 111:1633-1644 (Pubitemid 26404229)
10. Banales JM, Arenas F, Rodriguez-Ortigosa CM, Saez E, Uriarte I, Doctor RB, Prieto J, Medina JF: Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology 2006, 43:266-275
11. Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G: Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007, 132:415-431 (Pubitemid 46108729)
12. Roskams T, van den Oord JJ, De Vos R, Desmet VJ: Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 1990, 137:1019-1025
13. Marzioni M, Alpini G, Saccomanno S, de Minicis S, Glaser S, Francis H, Trozzi L, Venter J, Orlando F, Fava G, Candelaresi C, Macarri G, Benedetti A: Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 2006, 130:1831-1847 (Pubitemid 43668860)
14. Marzioni M, Glaser S, Francis H, Marucci L, Benedetti A, Alvaro D, Taffetani S, Ueno Y, Roskams T, Phinizy JL, Venter J, Fava G, LeSage G, Alpini G: Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 2005, 128:121-137 (Pubitemid 40039964)
15. 2+)- and PKC-dependent stimulation of cAMP. Hepatology 2004, 40:1116-1127
16. Francis H, LeSage G, DeMorrow S, Alvaro D, Ueno Y, Venter J, Glaser S, Mancino MG, Marucci L, Benedetti A, Alpini G: The α2- adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats. Am J Physiol Cell Physiol 2007, 293:C1252-C1262 (Pubitemid 47556728)
17. Glaser S, Alvaro D, Francis H, Ueno Y, Marucci L, Benedetti A, De Morrow S, Marzioni M, Mancino MG, Phinizy JL, Reichenbach R, Fava G, Summers R, Venter J, Alpini G: Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. Am J Physiol Gastrointest Liver Physiol 2006, 290:G813-G826
18. Marzioni M, Ueno Y, Glaser S, Francis H, Benedetti A, Alvaro D, Venter J, Fava G, Alpini G: Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver. Liver Int 2007, 27:558-568 (Pubitemid 46534578)
19. LeSage G, Alvaro D, Benedetti A, Glaser S, Marucci L, Baiocchi L, Eisel W, Caligiuri A, Phinizy JL, Rodgers R, Francis H, Alpini G: Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology 1999, 117:191-199 (Pubitemid 29297637)
20. Alvaro D, Alpini G, Jezequel AM, Bassotti C, Francia C, Fraioli F, Romeo R, Marucci L, Le Sage G, Glaser S, Benedetti A: Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest 1997, 100:1349-1362 (Pubitemid 27425759)
21. 2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts. Am J Pathol 2006, 168:398-409
22. Marzioni M, LeSage G, Glaser S, Patel T, Marienfeld C, Ueno Y, Francis H, Alvaro D, Tadlock L, Benedetti A, Marucci L, Baiocchi L, Phinizy JL, Alpini G: Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. Am J Physiol Gastrointest Liver Physiol 2003, 284:G837-G852 (Pubitemid 36437985)
23. Mancinelli R, Franchitto A, Gaudio E, Onori P, Glaser S, Francis H, Venter J, Demorrow S, Carpino G, Kopriva S, White M, Fava G, Alvaro D, Alpini G: After damage of large bile ducts by γ-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. Am J Pathol 2010, 176:1790-1800
24. DeMorrow S, Francis H, Gaudio E, Ueno Y, Venter J, Onori P, Franchitto A, Vaculin B, Vaculin S, Alpini G: Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol 2008, 294:G506-G519 (Pubitemid 351253342)
25. Francis H, Glaser S, Demorrow S, Gaudio E, Ueno Y, Venter J, Dostal D, Onori P, Franchitto A, Marzioni M, Vaculin S, Vaculin B, Katki K, Stutes M, Savage J, Alpini G: Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol 2008, 295:C499-C513 (Pubitemid 352755782)
26. Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, Gaudio E, Alvaro D, Fava G, Marzioni M, Vaculin B, Alpini G: H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 2007, 87:473-487 (Pubitemid 46633123)
27. Glaser S, Ueno Y, DeMorrow S, Chiasson VL, Katki KA, Venter J, Francis HL, Dickerson IM, DiPette DJ, Supowit SC, Alpini G: Knockout of α-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice. Lab Invest 2007, 87:914-926 (Pubitemid 47267811)
28. Alvaro D, Alpini G, Onori P, Franchitto A, Glaser S, Le Sage G, Gigliozzi A, Vetuschi A, Morini S, Attili AF, Gaudio E: Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 2002, 123:336-344 (Pubitemid 34747553)
29. Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A, Alpini G, Mancino MG, Attili AF, Gaudio E: Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 2002, 36:297-304 (Pubitemid 34810348)
30. Svegliati-Baroni G, Ghiselli R, Marzioni M, Alvaro D, Mocchegiani F, Saccomanno S, Sisti V, Ugili L, Orlando F, Alpini G, Saba V, Benedetti A: Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats. J Hepatol 2006, 44:1158-1166
31. Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-Corradini S, Mancino MG, Maggioni M, Attili AF, Podda M, Gaudio E: Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 2004, 41:905-912 (Pubitemid 39575656)
32. 2+)-, and protein kinase C α-dependent mechanisms, Hepatology 2000, 32:17-25
33. Glaser S, Rodgers RE, Phinizy JL, Robertson WE, Lasater J, Caligiuri A, Tretjak Z, LeSage G, Alpini G: Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol Gastrointest Liver Physiol 1997, 273:G1061-G1070
34. Alvaro D, Metalli VD, Alpini G, Onori P, Franchitto A, Barbaro B, Glaser S, Francis H, Cantafora A, Blotta I, Attili AF, Gaudio E: The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol 2005, 43:875-883 (Pubitemid 41414514)
35. Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, Francis H, Trozzi L, Glaser S, Benedetti A: Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Gastroenterology 2007, 133:244-255 (Pubitemid 47031126)
36. Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, Francis H, Trozzi L, Benedetti A: Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis. Gut 2009, 58:990-997
37. Gigliozzi A, Alpini G, Baroni GS, Marucci L, Metalli VD, Glaser S, Francis H, Mancino MG, Ueno Y, Barbaro B, Benedetti A, Attili AF, Alvaro D: Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 2004, 127:1198-1209 (Pubitemid 39345888)
38. Glaser S, DeMorrow S, Francis H, Ueno Y, Gaudio E, Vaculin S, Venter J, Franchitto A, Onori P, Vaculin B, Marzioni M, Wise C, Pilanthananond M, Savage J, Pierce L, Mancinelli R, Alpini G: Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol 2008, 295:G124-G136
39. Glaser S, Lam IP, Franchitto A, Gaudio E, Onori P, Chow BK, Wise C, Kopriva S, Venter J, White M, Ueno Y, Dostal D, Carpino G, Mancinelli R, Butler W, Chiasson V, DeMorrow S, Francis H, Alpini G: Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology 2010, 52:204-214
40. Alpini G, Glaser S, Ueno Y, Pham L, Podila PV, Caligiuri A, LeSage G, LaRusso NF: Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 1998, 274:G767-G775
41. Tietz PS, Alpini G, Pham LD, LaRusso NF: Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. Am J Physiol 1995, 269:G110-G118
42. Tracy TF Jr, Tector AJ, Goerke ME, Kitchen S, Lagunoff D: Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. Am J Pathol 1993, 143:1574-1578 (Pubitemid 24058261)
43. Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Ueno Y, Meininger CJ, Franchitto A, Onori P, Marzioni M, Taffetani S, Fava G, Stoica G, Venter J, Reichenbach R, De Morrow S, Summers R, Alpini G: Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 2006, 130:1270-1282
44. Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Franchitto A, Onori P, Ueno Y, Marzioni M, Fava G, Venter J, Reichenbach R, Summers R, Alpini G: Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol 2006, 291:G307-G317 (Pubitemid 44024691)
45. Fabris L, Cadamuro M, Fiorotto R, Roskams T, Spirli C, Melero S, Sonzogni A, Joplin RE, Okolicsanyi L, Strazzabosco M: Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology 2006, 43:1001-1012 (Pubitemid 43724625)
46. Amura CR, Brodsky KS, Groff R, Gattone VH, Voelkel NF, Doctor RB: VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice. Am J Physiol Cell Physiol 2007, 293:C419-C428 (Pubitemid 47105041)
47. Caligiuri A, Glaser S, Rodgers RE, Phinizy JL, Robertson W, Papa E, Pinzani M, Alpini G: Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. Am J Physiol Gastrointest Liver Physiol 1998, 275:G835-G846
48. Amura CR, Brodsky KS, Gitomer B, McFann K, Lazennec G, Nichols MT, Jani A, Schrier RW, Doctor RB: CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation. Am J Physiol Cell Physiol 2008, 294:C786-C796 (Pubitemid 351468696)
49. 2+-dependent PKC isoforms. BMC Physiol 2007, 7:6
50. Bogorad RL, Ostroukhova TY, Orlova AN, Rubtsov PM, Smirnova OV: Long isoform of prolactin receptor predominates in rat intrahepatic bile ducts and further increases under obstructive cholestasis. J Endocrinol 2006, 188:345-354 (Pubitemid 43273822)
51. Mancinelli R, Onori P, Gaudio E, DeMorrow S, Franchitto A, Francis H, Glaser S, Carpino G, Venter J, Alvaro D, Kopriva S, White M, Kossie A, Savage J, Alpini G: Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol 2009, 297:G11-G26
52. Kanno N, LeSage G, Glaser S, Alvaro D, Alpini G: Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology 2000, 31:555-561 (Pubitemid 30118620)
53. Ludwig J: New concepts in biliary cirrhosis. Semin Liver Dis 1987, 7:293-301
54. Alpini G, Glaser S, Robertson W, Rodgers RE, Phinizy JL, Lasater J, LeSage G: Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol Gastrointest Liver Physiol 1997, 272:G1064-G1074
55. Alpini G, Roberts S, Kuntz SM, Ueno Y, Gubba S, Podila PV, LeSage G, LaRusso NF: Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 1996, 110:1636-1643 (Pubitemid 26134100)
56. Glaser S, Gaudio E, Rao A, Pierce LM, Onori P, Franchitto A, Francis HL, Dostal DE, Venter JK, DeMorrow S, Mancinelli R, Carpino G, Alvaro D, Kopriva SE, Savage JM, Alpini G: Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest 2009, 89:456-469
57. Sparks EE, Huppert KA, Brown MA, Washington MK, Huppert SS: Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice. Hepatology 2010, 51:1391-1400
58. Masyuk TV, Ritman EL, LaRusso NF: Quantitative assessment of the rat intrahepatic biliary system by three-dimensional reconstruction. Am J Pathol 2001, 158:2079-2088 (Pubitemid 32545193)
59. Reilly FD, McCuskey PA, McCuskey RS: Intrahepatic distribution of nerves in the rat. Anat Rec 1978, 191:55-67 (Pubitemid 8345675)
60. Akiyoshi H, Gonda T, Terada T: A comparative histochemical and immunohistochemical study of aminergic, cholinergic and peptidergic innervation in rat, hamster, guinea pig, dog and human livers. Liver 1998, 18:352-359 (Pubitemid 28492952)
61. Gaudio E, Onori P, Pannarale L, Alvaro D: Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology 1996, 111:1118-1124 (Pubitemid 26327616)
62. Alpini G, Glaser S, Ueno Y, Rodgers R, Phinizy JL, Francis H, Baiocchi L, Holcomb LA, Caligiuri A, LeSage G: Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 1999, 116:179-186 (Pubitemid 29013507)
63. Francis H, Glaser S, Ueno Y, LeSage G, Marucci L, Benedetti A, Taffetani S, Marzioni M, Alvaro D, Venter J, Reichenbach R, Fava G, Phinizy JL, Alpini G: cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 2004, 41:528-537 (Pubitemid 39297786)
64. Alpini G, Invernizzi P, Gaudio E, Venter J, Kopriva S, Bernuzzi F, Onori P, Franchitto A, Coufal M, Frampton G, Alvaro D, Lee SP, Marzioni M, Benedetti A, DeMorrow S: Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 2008, 68:9184-9193
65. Alpini G, Phinizy JL, Glaser S, Francis H, Benedetti A, Marucci L, LeSage G: Development and characterization of secretin-stimulated secretion of cultured rat cholangiocytes. Am J Physiol Gastrointest Liver Physiol 2003, 284:G1066-G1073 (Pubitemid 36597350)
66. Kyriatsoulis A, Manns M, Gerken G, Lohse AW, Maelicke A, Wessler I, Reske K, Meyer zum Buschenfelde KH: Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis. J Hepatol 1988, 6:283-290
67. Keresztes K, Istenes I, Folhoffer A, Lakatos PL, Horvath A, Csak T, Varga P, Kempler P, Szalay F: Autonomic and sensory nerve dysfunction in primary biliary cirrhosis. World J Gastroenterol 2004, 10:3039-3043 (Pubitemid 39303059)
68. Iwai M, Shimazu T: Alteration in sympathetic nerve activity during liver regeneration in rats after partial hepatectomy. J Auton Nerv Syst 1992, 41:209-214 (Pubitemid 23000510)
69. Jones EA, Bergasa NV: The pathogenesis and treatment of pruritus and fatigue in patients with PBC. Eur J Gastroenterol Hepatol 1999, 11:623-631 (Pubitemid 29348979)
70. Charron L, Peyronnard JM, Marchand L: Sensory neuropathy associated with primary biliary cirrhosis: histologic and morphometric studies. Arch Neurol 1980, 37:84-87 (Pubitemid 10174386)
71. Floreani A, Lazzari R, Macchi V, Porzionato A, Variola A, Colavito D, Leon A, Guido M, Baldo V, De Caro R, Bergasa NV: Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis. J Gastroenterol 2010, 45:68-76
72. Strazzabosco M, Fiorotto R, Melero S, Glaser S, Francis H, Spirli C, Alpini G: Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology 2009, 50:244-252
73. Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieto J: Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994, 19:1400-1406 (Pubitemid 24166460)
74. Marzioni M, Glaser S, Francis H, Phinizy JL, LeSage G, Alpini G: Functional heterogeneity of cholangiocytes. Semin Liver Dis 2002, 22:227-240
75. Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I, Oude Elferink RP, Prieto J, Medina JF: Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008, 134:1482-1493 (Pubitemid 351626951)
76. Hellund JC, Skattum J, Buanes T, Geitung JT: Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticobiliary tract. Acta Radiol 2007, 48:135-141 (Pubitemid 46396982)
77. Prieto J, Garcia N, Marti-Climent JM, Penuelas I, Richter JA, Medina JF: Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology 1999, 117:167-172 (Pubitemid 29297634)
78. Masyuk TV, Masyuk AI, Torres VE, Harris PC, LaRusso NF: Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 2007, 132:1104-1116 (Pubitemid 46440866)
79. Masyuk T, Masyuk A, LaRusso N: Cholangiociliopathies: genetics, molecular mechanisms and potential therapies. Curr Opin Gastroenterol 2009, 25:265-271
80. Drucker DJ: Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 2003, 17:161-171
81. Miyatsuka T, Kaneto H, Kajimoto Y, Hirota S, Arakawa Y, Fujitani Y, Umayahara Y, Watada H, Yamasaki Y, Magnuson MA, Miyazaki J, Hori M: Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. Biochem Biophys Res Commun 2003, 310:1017-1025 (Pubitemid 37188724)
82. Fouassier L, Rosenberg P, Mergey M, Saubamea B, Claperon A, Kinnman N, Chignard N, Jacobsson-Ekman G, Strandvik B, Rey C, Barbu V, Hultcrantz R, Housset C: Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 2009, 174:869-880
83. Invernizzi P, Alvaro D, Crosignani A, Gaudio E, Podda M: Tamoxifen in treatment of primary biliary cirrhosis. Hepatology 2004, 39:1175-1176 (Pubitemid 38428959)
84. Beckmann MW, Jap D, Djahansouzi S, Nestle-Kramling C, Kuschel B, Dall P, Brumm C, Bender HG: Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates. Oncology 2001, 60:199-206 (Pubitemid 32424524)
85. Reddy A, Prince M, James OF, Jain S, Bassendine MF: Tamoxifen: a novel treatment for primary biliary cirrhosis? Liver Int 2004, 24:194-197
86. Sheen-Chen SM, Ho HT, Chen WJ, Sheen CW, Eng HL, Chou FF: Progesterone receptor in patients with hepatolithiasis. Dig Dis Sci 2001, 46:2374-2377
87. Zenkova TY, Kulikov AV, Bogorad RL, Rozenkrants AA, Platonova LV, Shono NI, Gal'perin EI, Smirnova OV: Expression of prolactin receptors in human liver during cholestasis of different etiology and secondary liver cancer. Bull Exp Biol Med 2003, 135:566-569
88. Ilan Y, Oren R, Tur-Kaspa R: Elevated growth hormone levels in patients with non-alcoholic chronic liver disease. J Gastroenterol Hepatol 1993, 8:448-450 (Pubitemid 23271819)
89. Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ: Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991, 38:531-534
90. Onori P, Franchitto A, Mancinelli R, Carpino G, Alvaro D, Francis H, Alpini G, Gaudio E: Polycystic liver diseases. Dig Liver Dis 2010, 42:261-271
91. Nicoll J, Axiotis CA, Bergasa NV: The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses 2005, 65:1099-1105 (Pubitemid 41425896)
92. Owczarek D, Garlicka M, Pierzchala-Koziec K, Skulina D, Szulewski P: Met-enkephalin plasma concentration and content in liver tissue in patients with primary biliary cirrhosis (in Polish). Przegl Lek 2003, 60:461-466
93. Bergasa NV, Liau S, Homel P, Ghali V: Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis. Liver 2002, 22:107-113 (Pubitemid 34591250)
94. Castaing D, Houssin D, Bismuth H: Anatomy of the liver and portal system.Hepatic and Portal Surgery in the Rat, ch 6. Edited by D Castaing, D Houssin, H Bismuth. Paris, Masson, 1980, pp 27-45
95. Tavoloni N, Schaffner F: The intrahepatic biliary epithelium in the guinea pig: is hepatic artery blood flow essential in maintaining its function and structure? Hepatology 1985, 55:666-672
96. Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M: Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology 2010, 51:1778-1788
97. Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, Sun JZ, Stockard CR, Frost AR, Chen YF, Grizzle WE, Fallon MB: Cholangiocyte endothelin 1 and transforming growth factor β1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 2005, 129:682-695 (Pubitemid 41096652)
98. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB: ET-1 and TNF-α in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol 2004, 286:G294-G303 (Pubitemid 38134041)
99. Gatto M, Drudi-Metalli V, Torrice A, Alpini G, Cantafora A, Blotta I, Alvaro D: Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury. Lab Invest 2008, 88:986-994
100. He Y, Wu GD, Sadahiro T, Noh SI, Wang H, Talavera D, Vierling JM, Klein AS: Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers. Am J Physiol Gastrointest Liver Physiol 2008, 295:G305-G312